Efficacy and safety of injectable quinine for the treatment of malaria in Japa
Not Applicable
- Conditions
- malaria
- Registration Number
- JPRN-UMIN000027485
- Lead Sponsor
- niversity of Miyazaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are allergic to injectable quinine or related compounds 2) Patients who do not agree to give written informed consent 3) Patients principal who investigator considers inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cure rate
- Secondary Outcome Measures
Name Time Method 1) time required for fever disappearance 2) parasite clearance time 3) recurrence after 28 days of treatment